The lipid disorders therapy in overweight patients
Journal Title: Archives of Medical Science - Year 2005, Vol 1, Issue 4
Abstract
Introduction: The study was aimed to assess effects of hypercholesterolemia and the dyslipidemia therapy within one year of recommended lifestyle and diet modifications. Material and methods: The study included 157 consecutive patients referred to the Outpatient Department of Metabolic Disorders with hypercholesterolemia diagnosis. Patients were assigned based on body weight and BMI into three groups: 1) patients with normal body weight (BMI 18.525-30) and 3) obese patients (BMI >30). The therapeutical effects were studied 6 and 12 months after the initiated therapy. The degree of body weight reduction, incidence and time frame of normal lipid panel, incidence and time of drop-outs in relation to the remaining IND and CVI risk factors were studied. Results: Total cholesterol was significantly increased before the study in overweight patients. After 6 months, the percentage of patients who reached the therapeutical targets was 30.56% in obese patients, 35.29% in overweight patients, and 29.41% in patients with normal body weight. After 12 months, the highest percentage of patients reaching therapeutical targets was 47.06% in the group with normal body weight. Conclusions: 1. Time frame and incidence of successful therapy and eventual, normal lipids panel is remarkably related with initial body weight. 2. Subjects with normal body weight benefited from the 12 months therapy to the largest extent. 3. Overweight and obese patients are less motivated to diet and lifestyle changes resulting in the highest number of patients with increased body weight during the dyslipidemia therapy.
Authors and Affiliations
Jacek Rysz, Maciej Banach, Robert Stolarek, Leszek Markuszewski, Radosław Wilk
Keywords
Related Articles
- EP ID EP96467
- DOI -
- Views 186
- Downloads 0
The estimation of clinical and home-based tilt training efficacy
The role of trimetazidine in inhibiting cardiomyocyte apoptosis
The association of 25-hydroxyvitamin D levels with secondary hyperparathyroidism in end-stage renal failure patients undergoing regular hemodialysis
Introduction: To investigate the role of 25-OHD as a marker of nutrition and its association with mineral metabolism and serum parathormone secretion in end-stage renal failure patients undergoing regular hemodialysis (H...
The role of statins in patients with arterial hypertension
B-type natriuretic peptide level in adult patients after successful repair of coarctation of the aorta